ExodusPoint Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.2M | Buy |
108,606
+64,315
| +145% | +$15.5M | 0.23% | 57 |
|
|
2025
Q1 | $10.8M | Buy |
44,291
+28,484
| +180% | +$6.94M | 0.11% | 167 |
|
|
2024
Q4 | $5.19M | Buy |
+15,807
| New | +$5.19M | 0.04% | 398 |
|
|
2024
Q1 | – | Sell |
-4,544
| Closed | -$1.47M | – | 1370 |
|
|
2023
Q4 | $1.47M | Buy |
4,544
+104
| +2% | +$33.6K | 0.01% | 625 |
|
|
2023
Q3 | $1.59M | Buy |
4,440
+1,411
| +47% | +$506K | 0.02% | 722 |
|
|
2023
Q2 | $1.15M | Sell |
3,029
-4,212
| -58% | -$1.6M | 0.01% | 962 |
|
|
2023
Q1 | $3.47M | Buy |
7,241
+6,372
| +733% | +$3.05M | 0.03% | 570 |
|
|
2022
Q4 | $365K | Sell |
869
-27,735
| -97% | -$11.6M | 0.01% | 1252 |
|
|
2022
Q3 | $11.9M | Buy |
28,604
+16,090
| +129% | +$6.71M | 0.16% | 157 |
|
|
2022
Q2 | $6.19M | Sell |
12,514
-2,191
| -15% | -$1.08M | 0.08% | 313 |
|
|
2022
Q1 | $8.28M | Buy |
14,705
+9,186
| +166% | +$5.17M | 0.1% | 215 |
|
|
2021
Q4 | $4.17M | Buy |
5,519
+1,980
| +56% | +$1.5M | 0.04% | 476 |
|
|
2021
Q3 | $2.64M | Buy |
+3,539
| New | +$2.64M | 0.04% | 575 |
|
|
2021
Q2 | – | Sell |
-8,765
| Closed | -$5.01M | – | 2275 |
|
|
2021
Q1 | $5.01M | Buy |
8,765
+8,164
| +1,358% | +$4.66M | 0.07% | 248 |
|
|
2020
Q4 | $350K | Sell |
601
-2,959
| -83% | -$1.72M | ﹤0.01% | 1377 |
|
|
2020
Q3 | $1.84M | Sell |
3,560
-2,541
| -42% | -$1.31M | 0.04% | 396 |
|
|
2020
Q2 | $2.76M | Buy |
+6,101
| New | +$2.76M | 0.07% | 296 |
|
|
2019
Q4 | – | Sell |
-35,415
| Closed | -$11.8M | – | 1478 |
|
|
2019
Q3 | $11.8M | Buy |
+35,415
| New | +$11.8M | 0.41% | 46 |
|